TY  - JOUR 
AU  - Cerveró García, Pilar
AU  - Jiménez Madrona, Enrique
AU  - Álvarez Vázquez, Andrea
AU  - Flores Hernández, Raquel
AU  - García Vicente, Laura
AU  - García Guerrero, Laura
AU  - Alonso Amador, Juan José
AU  - González Sánchez, Raúl
AU  - Ollauri Ibáñez, Claudia
AU  - Paniagua Sancho, María
AU  - Talaverón Aguilocho, Rocío
AU  - Rodrigues Teixeira, Telmo
AU  - Martín Guerrero, Sandra M.
AU  - Casado, Pedro
AU  - Rajeeve, Vinothini
AU  - Shields, Tommy
AU  - Hijazi Vega, Maruan
AU  - Cutillas, Pedro R
AU  - Jaraíz Rodríguez, Myriam
AU  - Tabernero Urbieta, María Aránzazu
PY  - 2026
UR  - http://hdl.handle.net/10366/169127
AB  - [EN] Background: TAT-Cx43266-283 is a novel Src inhibitor, which has shown noteworthy antitumor effects in preclinical models of glioblastoma. Because Src plays a pivotal role in several tumor types, including lung cancer brain metastasis derived from...
LA  - eng
PB  - Oxford University Press
KW  - Brain metastasis
KW  - lung cancer
KW  - CSCs
KW  - Src
KW  - Connexin
TI  - The src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial model of lung cancer brain metastasis in mice
DO  - 10.1093/noajnl/vdag001
T2  - Neuro-Oncology Advances
ER  -